当前位置:公众访问 >页面
简体中文 / English
1.Screening

Investigator signature

陈涧杨

1.Inclusion Criteria

Age 18-80 years

Yes

Diagnosis of end-stage renal disease and a preference for hemodialysis

Yes

Initial arteriovenous fistula creation on the surgical side of the upper extremity, meeting vascular criteria outlined in Figure 3, including a patent return vein, a cephalic vein diameter ≥ 2 mm, a postoperative cannulation length of ≥10 cm, radial artery diameter ≥ 1.5 mm, and a distance between t

Yes

Expected survival duration >12 months

Yes

Informed consent and willingness to participate in clinical follow-up

Yes

2.Exclusion Criteria

Those currently enrolled in another clinical trial involving drugs or medical devices

No

Pregnant or breastfeeding women

No

Patients with an ejection fraction (EF) <30% as assessed by echocardiography

No

Patients with severe pathological changes in other organs, including the cardiovascular and cerebrovascular systems, within the past month.

No

Patients with a life expectancy of less than one year

No

Patients with central venous lesions on the operative side, including a history of central venous catheterization, breast cancer surgery, cardiac pacemaker implantation, or other central venous

No

Patients diagnosed with severe infections

No

Patients with arterial stenosis on the operative side.

No

2.Baseline

Investigator signature

陈涧杨

1.General information

date of birth

1962年06月10日

sex

height

170 CM

weight

70 Kg

2.Physical examination

blood pressure

143/82 mmHg

temperature

36.8

heart rate

84 次/分

3.Primary disease

Primary diseases

糖尿病肾病

4.Complication

complication

高血压病;糖尿病视网膜病变

5.Other medical history

Is blood pressure normal?

abnormal

smoking history

NO

Drinking history

No

allergic history

No

6.Vascular access history

History of central venous catheterization

No

History of vascular access surgery

No VA history

Surgical history of other affected VA

No

7.Preoperative ultrasound vascular assessment

Preoperative vascular ultrasound evaluation

/uploads/patrecord/11788/param512688/9831ef13-12fe-4d97-a553-2f3cf99ab125.jpg

10.Coagulation Function Tests

coagulation funtion tests

/uploads/patrecord/11788/param512691/b2eb9e5d-91d5-4b9b-b6d6-206b6ee56ada.pdf

11.Serum Liver and Renel Function Tests

serum liver and renel function tests

/uploads/patrecord/11788/param512692/32d74624-8df8-447f-9e52-0d6745d87601.pdf

13.Heat Function Examination

Cardiac function test

/uploads/patrecord/11788/param512694/3a66cbee-c73b-4bfc-97ef-79237db0782c.jpg

14.Pregnancy tests

pregnancy tests

No

Pregnancy test results

3.Intraoperative
1.Surgery information

date of surgery

2025年04月25日

Operation start time

16时25分

End of operation time

15时07分

anesthesia method

limb

3.Intraoperative medication

4.Post-operative management (infrared, anticoagulation, etc.)

4.Follow-up 1
1.Visit status

Visit status

2.Follow-up method

Follow-up method

3.Follow-up date

Follow-up date

4.HD
4.4.1、Deprecate or not

abandon

4.4.2、First dialysis time

First dialysis time

4.4.3、Pumps control blood flow

Pumps control blood flow

4.4.4、Is HD successful?

Is HD successful?

4.4.5、HD or not

HD

5.US results

US results

6.Intervention or not

Intervention

Intervention

7.Hospitalization

Hospitalization

Cause of hospitalization

8.Death

death time

death

5.Follow-up 2
1.Visit status

visit status

2.Follow-up method

Follow-up method

3.Follow-up date

Follow-up date

4.Intervetion or not

Intervetion or not

Intervention

5.Hospitalization

Hospitalization

Cause of hospitalization

6.Death

Death

cause of death

6.Follow-up 3
1.Visit status

Visit status

2.Follow-up method

Follow-up method

3.Follow-up date

Follow-up date

4.HD
6.4.1、Deprecate or not

Deprecate or not

6.4.2、HD or not

HD or not

6.4.3、First dialysis time

First dialysis time

6.4.4、Pumps control blood flow

PCDF

6.4.5、Is HD successful?

Is HD successful?

5.US results

US results

6.Intervetion or not

intervention method

Intervention or not

7.Hospitalization

Cause of hospitalization

Hospitalization

8.Death

cause of death

death

7.Follow-up 4
1.Visit status

Visit status

2.Follow-up method

Follow-up method

3.Follow-up date

Follow-up date

4.HD
7.4.1、Deprecate or not

Deprecate or not

7.4.2、HD or not

HD or not

7.4.3、First dialysis time

First dialysis time

7.4.4、PCBF

PCBF

7.4.5、Is HD successful?

Is HD successful?

5.US results

US results

6.Intervetion or not

Intervention method

Intervention or not

7.Hospitalization

Hospitalization

Cause of hospitalization

8.Death

cause of death

death

8.ADR/ADE management system
1.ADR/ADE 1

Name of adverse event

SAE or not

end time

prognosis

take action

Relationship with surgical procedure

Severity Degree

Adverse event characteristics

date

incident description

2.ADR/ADE 2
9.Scheme deviation
1.Scenarios deviate from the stage in which they occur

Stage

2.Scheme deviation type

Failure to follow protocol for examination and treatment

Follow-up was not conducted according to the study process time window

AE/SAE does not meet reporting requirements

loss to follow-up

Violation of inclusion/exclusion criteria

Informed consent issue

other

10.Study completed/discontinued early
11.Institutions
1.Longhua Hospital Shanghai University of Traditional Chinese Medicine
2.Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University
3.Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
4.Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
5.The First Affiliated Hospital of Sun Yat-sen University
6.The First Affiliated Hospital of Dalian Medical University
7.The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
8.Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
9.China-Japan Friendship Hospital
10.Affiliated Hospital of Jiangsu University
11.Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
12.Suzhou Municipal Hospital, The affiliated Suzhou Hospital of Nanjing Medical University
13.The First Affiliated Hospital, Zhejiang University School of Medicine
14.Guangdong provincial hospital of Chinese Medicine Hainan Hospital
15.Mianyang Central Hospital
16.Jinling Hospital, Nanjing University School of Medicine
17.Affiliated Cancer Hosptial of Guizhou Medical University
18.NO.2 People's Hospital of Fuyang City
19.Suzhou Hospital of Integrated Traditional Chinese and Western Medicine
20.The First Affiliated Hospital of Zhengzhou University
21.Taizhou Hospital of Zhejiang Province
22.People's Hospital of Suzhou New District
23.The second people's hospital, Wuhu
24.Anqing Shengtong Nephropathy Hospital
25.The Second Affiliated Hospital of Anhui Medical University
26.Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Science), Southern Medical University
27.The First Hospital of Hebei Medical University
28.The NO.1 Affiliated Hospital of Kunming Medical University
29.Beijing Haidian Hospital (Haidian Section, Peking University Third Hospital)
12.Researchers